Activaero has entered into research collaboration with Italian pharmaceutical firm Chiesi Farmaceutici to develop an effective solution to treat patients with cystic fibrosis (CF). Under the deal, Activaero will offer its flow and volume ...
Germany-based Activaero has extended its collaboration agreement with TransMIT, Gesellschaft für Technologietransfer, the technology transfer agency of Justus-Liebig-University Giessen, to develop the treatment of pulmonary ...
Tags: Pulmonary Hypertension, Health
Activaero has reported the positive results from its phase II trial in children with mild to moderate asthma. The proof-of-concept trial was conducted with Activaero's drug-device combination consisting of budesonide in liquid formulation ...
Tags: Activaero, phase II trial, moderate asthma